Scleroderma and the taxanes. Is there really a link?

Clinical and Experimental Dermatology

Volumn 29, Issue 4, 2004, Pages 360-362

  Farrant, P B J ^a,c   Mortimer, P S ^a   Gore, M ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c BRIGHTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CAPECITABINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; PACLITAXEL; TAXANE DERIVATIVE; TOPOTECAN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; LABORATORY TEST; OVARY CANCER; PRIORITY JOURNAL; SCLERODERMA; SHORT SURVEY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ERUPTIONS; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; SCLERODERMA, SYSTEMIC;

EID: 3242781684     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01519.x     Document Type: Short Survey

References (6)

1. Battafarano DF, Zimmerman GC, Older SA et al. Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases. Cancer 1995; 76: 110-5.
2. Ene-Stroescu D, Ellman MH, Peterson CE. Topotecan and the development of scleroderma or a scleroderma-like illness. Arthritis Rheum 2002; 46: 844-5.
3. Cleveland MG, Ajaikumar BS, Reganti R. Cutaneous fibrosis induced by docetaxel: a case report. Cancer 2000; 88: 1078-81.
4. Hassett G, Harnett P, Manolios N. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 2001; 19: 197-200.
5. Lauchli S, Trueb RM, Fehr M, Hafner J. Scleroderma-like drug reaction to paclitaxel (taxol). Br J Dermatol 2002; 147: 619-21.
6. Kupfer I, Balguerie X, Courville P et al. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol 2003; 48: 279-81.